Wakefield Asset Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Wakefield Asset Management's AMGN Position: Q1 2026 in Review
Wakefield Asset Management reduced its Amgen (AMGN) stake by 0.84% in Q1 2026, selling an estimated $6.06K and leaving 2,008 shares worth $707K. The position accounts for 0.19% of the portfolio, ranked #144.
Wakefield Asset Management first reported a position in AMGN in Q3 2019 and has held it in 12 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Wakefield Asset Management held 2,008 shares of Amgen worth $707K as of Q1 2026.
- Wakefield Asset Management sold 17 Amgen shares in Q1 2026, an estimated $6.06K.
- Amgen made up 0.19% of Wakefield Asset Management's portfolio in Q1 2026, its #144 holding.
- Wakefield Asset Management first reported a position in Amgen in Q3 2019 and has held it in 12 quarters since.
- 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Wakefield Asset Management's 13F filing for Q1 2026, filed 12 May 2026.